| CPT SLAT 223 vs Lili | 4–12 | 25.00% |
| CPT SLAT 223 vs Reina | 6–9 | 40.00% |
| CPT SLAT 223 vs Azucena | 5–10 | 33.33% |
| CPT SLAT 223 vs King | 6–8 | 42.86% |
| CPT SLAT 223 vs Hwoarang | 2–10 | 16.67% |
| CPT SLAT 223 vs Jin | 3–8 | 27.27% |
| CPT SLAT 223 vs Lidia | 5–5 | 50.00% |
| CPT SLAT 223 vs Steve | 1–8 | 11.11% |
| CPT SLAT 223 vs Dragunov | 5–3 | 62.50% |
| CPT SLAT 223 vs Lee | 3–5 | 37.50% |
| CPT SLAT 223 vs Law | 1–6 | 14.29% |
| CPT SLAT 223 vs Alisa | 3–4 | 42.86% |
| CPT SLAT 223 vs Leroy | 3–3 | 50.00% |
| CPT SLAT 223 vs Asuka | 3–2 | 60.00% |
| CPT SLAT 223 vs Lars | 1–4 | 20.00% |
| CPT SLAT 223 vs Eddy | 1–4 | 20.00% |
| CPT SLAT 223 vs Bryan | 1–3 | 25.00% |
| CPT SLAT 223 vs Leo | 0–4 | 0.00% |
| CPT SLAT 223 vs Nina | 0–4 | 0.00% |
| CPT SLAT 223 vs Jun | 0–4 | 0.00% |
| CPT SLAT 223 vs Victor | 4–0 | 100.00% |
| CPT SLAT 223 vs Heihachi | 0–4 | 0.00% |
| CPT SLAT 223 vs Yoshimitsu | 3–0 | 100.00% |
| CPT SLAT 223 vs Kazuya | 0–3 | 0.00% |
| CPT SLAT 223 vs Claudio | 0–3 | 0.00% |
| CPT SLAT 223 vs Clive | 0–3 | 0.00% |
| CPT SLAT 223 vs Anna | 1–2 | 33.33% |
| CPT SLAT 223 vs Xiaoyu | 0–1 | 0.00% |
| CPT SLAT 223 vs Jack-8 | 0–1 | 0.00% |
| CPT SLAT 223 vs Devil Jin | 0–1 | 0.00% |
| CPT SLAT 223 vs Feng | 0–1 | 0.00% |
| CPT SLAT 223 vs Shaheen | 1–0 | 100.00% |
| CPT SLAT 223 vs Kuma | 1–0 | 100.00% |
Limitations
This data is often requested to give insight into which characters you have more trouble with than others, but it is not particularly helpful for that. The main issue is that it is heavily skewed by how strong the opponents you play are.
For example, this data suggests my worst matchup is clearly vs Reina, but that's just because most of those games are vs Yagami.
There is a way to account for this being worked on. The central idea is to assign each matchup a rating vs you which adjusts based on the result, much like the regular rating but also based on the rating of each player. With this, it would give a better summary of how well you perform vs each character.
In the meantime, this page is here to present the data as requested.